东亚药业跌3.55% 2020年上市2募资共15.74亿

Group 1 - The stock price of Dongya Pharmaceutical (605177.SH) has dropped to 20.36 yuan, a decline of 3.55%, currently in a state of breaking the issue price [1] - Dongya Pharmaceutical was listed on the Shanghai Stock Exchange on November 25, 2020, with an issue price of 31.13 yuan per share, and the stock price fell below the issue price on February 8, 2021 [1] - The total number of shares issued by Dongya Pharmaceutical was 28.4 million, with a total fundraising amount of 884 million yuan, and a net amount of 782 million yuan after deducting issuance costs [1] Group 2 - The company has been approved to issue 6.9 million convertible bonds, with a total fundraising amount of 69 million yuan, and a net amount of 68.01844 million yuan after deducting issuance costs [2] - The funds raised from the bond issuance were fully in place as of July 12, 2023, and verified by Zhonghui Accounting Firm [2] - Since its listing, the company has raised funds twice, totaling 1.574 billion yuan [3]